Jane Street Group, LLC Intra Cellular Therapies, Inc. Put Options Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Put Options

11 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$67.99 - $80.84 $890,668 - $1.06 Million
13,100 New
13,100 $957,000
Q1 2022

May 17, 2022
SELL
$38.74 - $62.09 $127,842 - $204,897
-3,300 Reduced 8.53%
35,400 $2.17 Million
Q4 2021

Feb 15, 2022
BUY
$35.2 - $53.42 $1.12 Million - $1.7 Million
31,900 Added 469.12%
38,700 $2.03 Million
Q3 2021

Nov 16, 2021
SELL
$28.72 - $42.49 $347,512 - $514,129
-12,100 Reduced 64.02%
6,800 $254,000
Q2 2021

Aug 16, 2021
BUY
$29.3 - $44.5 $131,850 - $200,250
4,500 Added 31.25%
18,900 $771,000
Q1 2021

May 18, 2021
SELL
$30.8 - $39.51 $1.03 Million - $1.32 Million
-33,400 Reduced 69.87%
14,400 $489,000
Q4 2020

Feb 17, 2021
SELL
$23.34 - $32.22 $1.21 Million - $1.68 Million
-52,000 Reduced 52.1%
47,800 $1.52 Million
Q3 2020

Nov 17, 2020
SELL
$17.61 - $31.86 $2.82 Million - $5.1 Million
-160,100 Reduced 61.6%
99,800 $2.56 Million
Q2 2020

Aug 17, 2020
BUY
$14.35 - $26.64 $3.5 Million - $6.5 Million
244,000 Added 1534.59%
259,900 $6.67 Million
Q1 2020

May 15, 2020
SELL
$12.31 - $33.12 $1.66 Million - $4.47 Million
-135,100 Reduced 89.47%
15,900 $244,000
Q4 2019

Feb 14, 2020
BUY
$7.26 - $38.49 $1.1 Million - $5.81 Million
151,000 New
151,000 $5.18 Million

Others Institutions Holding ITCI

# of Institutions
378
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.16B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email